Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Classificação em ações #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Preço da ação
$7.15
Valor de mercado
$313.60M
Variação (1 dia)
-2.12%
Variação (1 ano)
-84.14%
País
DE
Negociar Anbio Biotechnology Class A Ordinary Shares (NNNN)

Categoria

Histórico de rendimento de dividendos para Anbio Biotechnology Class A Ordinary Shares (NNNN)
O rendimento de dividendos (TTM) da Anbio Biotechnology Class A Ordinary Shares (símbolo da ação: NNNN) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Anbio Biotechnology Class A Ordinary Shares (NNNN) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
0.00%
US
2.49%
FR
0.00%
JP
1.99%
US
0.00%
CH